Coronary artery disease in young patients with systemic lupus erythematosus: two case reports

Ettore Astorri1, Paolo Pattoneri, Arianna Arisi

  • 1Chair of Cardiology, Department of Clinical Sciences, University of Parma, Parma, Italy. ettore.astorri@unipr.it

Insights

Systemic lupus erythematosus (SLE) can affect the heart, leading to coronary artery disease in young patients. This study highlights two cases of myocardial ischemia and infarction in adolescents and young adults with SLE.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with potential cardiovascular complications.
  • Cardiovascular involvement in SLE, particularly myocardial ischemia and infarction in young patients, is underreported.
  • Early recognition and management of cardiac issues in SLE are crucial for long-term outcomes.

Observation:

  • Two young patients with SLE presented with distinct clinical manifestations of coronary artery disease.
  • Case 1: A 26-year-old woman with a history of SLE experienced progressive angina, leading to the diagnosis of a completely obstructed left anterior descending artery (LAD).
  • Case 2: A patient presented with myopericarditis and acute myocardial infarction, subsequently diagnosed with SLE, also showing complete LAD obstruction.

Findings:

  • The study identified coronary artery disease, including complete LAD obstruction, in two young SLE patients.
  • Clinical presentations varied, ranging from effort angina to acute myocardial infarction and myopericarditis.
  • Diagnostic tools like myocardial scintigraphy and coronary angiography were instrumental in identifying the extent of coronary artery disease.

Implications:

  • These cases underscore the importance of considering coronary artery disease in young SLE patients presenting with cardiac symptoms.
  • Timely diagnosis and intervention, including surgical revascularization, can be effective in managing SLE-related coronary artery disease.
  • Further research is warranted to elucidate the mechanisms and prevalence of cardiovascular involvement in pediatric and young adult SLE.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...